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Copper-zinc superoxide dismutase (SOD1) plays a protective
role against oxidative stress. On the other hand, recent studies
suggest that SOD1 itself is a major target of oxidative damage
and has its own pathogenicity in various neurodegenerative dis-
eases, including familial amyotrophic lateral sclerosis. Only
human and great ape SOD1s among mammals have the highly
reactive free cysteine residue, Cys111, at the surface of the SOD1
molecule. The purpose of this studywas to investigate the role of
Cys111 in the oxidative damage of the SOD1 protein, by compar-
ing the oxidative susceptibility of recombinant human SOD1
modified with 2-mercaptoethanol at Cys111 (2-ME-SOD1) to
wild-type SOD1. Wild-type SOD1 was more sensitive to oxida-
tion by hydrogen peroxide-generating fragments, oligomers,
and charge isomers compared with 2-ME-SOD1. Moreover,
wild-type SOD1, but not 2-ME-SOD1, generated an upper
shifted band in reducing SDS-PAGE even by air oxidation.
Using mass spectrometry and limited proteolysis, this upper
band was identified as an oxidized subunit of SOD1; the sulfhy-
dryl group (Cys-SH) of Cys111 was selectively oxidized to cys-
teine sulfinic acid (Cys-SO2H) and to cysteine sulfonic acid
(Cys-SO3H). The antibody raised against a synthesized peptide
containing Cys111-SO3H reacted with only the Cys111-peroxi-
dized SOD1 by Western blot analysis and labeled Lewy body-
like hyaline inclusions and vacuole rims in the spinal cord of
human SOD1-mutated amyotrophic lateral sclerosis mice by
immunohistochemical analysis. These results suggest that
Cys111 is a primary target for oxidative modification and plays
an important role in oxidative damage to human SOD1, includ-
ing familial amyotrophic lateral sclerosis mutants.
Copper-zinc superoxide dismutase (Cu/Zn-SOD)3 (SOD1) is
a homodimer containing one copper ion and one zinc ion in
each 16-kDa subunit. SOD1 catalyzes the conversion of super-
oxide anion (O2) into O2 and H2O2, thereby protecting cells
against oxidative stress. On the other hand, SOD1 exhibits per-
oxidase activity and oxidizes various substrates in the presence
of hydrogen peroxide, H2O2 (1). Although H2O2 is a substrate
as well as a product of SOD1, incubation of bovine SOD1 with
H2O2 caused oxidation of His118 (corresponding to His120 in
human SOD1) to 2-oxohistidines, inactivating the enzyme (2).
Moreover, incubation with excess H2O2 caused oxidation of
almost all histidine and cysteine residues (3), fragmentation (4,
5) and aggregation (6, 7) of SOD1 itself. Co-incubation with
bicarbonate and H2O2 also induced bicarbonate radical anion
formation, resulting in oligomerization of human SOD1 (8).
The familial form of amyotrophic lateral sclerosis (ALS) is
associated with specific mutations in the SOD1 gene (SOD1)
that encodes 153 amino acids (9, 10). To date, more than 110
familial ALS (FALS)-causing mutations in SOD1 have been
identified (available on the World Wide Web); however, the
mechanism by which SOD1 mutants induce ALS remains
unknown. The presence of intracellular aggregates that contain
SOD1 in spinal cord motor neurons is thought to be a patho-
logical hallmark of ALS. In particular, FALS-linked mutant
SOD1s are prone to misfolding and aggregation (11, 12).
Recently, Ezzi et al. (7) reported that even wild-type SOD1
results in aggregation after oxidation, and the oxidized wild-
type SOD1 gains properties like FALS mutant SOD1s. In addi-
tion to ALS, oxidative damaged SOD1 proteins were detected
in the brains of patients with Alzheimer and Parkinson diseases
(13). These findings suggest that oxidized SOD1 plays a role in
the pathophysiology of various neurodegenerative diseases.
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However, the role of oxidized wild-type and FALS-linked
mutant SOD1s on these diseases remains unclear.
Human SOD1 has four cysteine residues, Cys6, Cys57, Cys111,
andCys146. An internal disulfide bond exists betweenCys57 and
Cys146 (14, 15), which contributes to the high stability of the
SOD1 protein. This disulfide bond is highly conserved in
SOD1s from various organisms, including yeast, plants, flies,
fishes, and mammals. In contrast, two free cysteines, Cys6 and
Cys111, are not conserved. Actually, yeast, fungi, and spinach
(plants) have no free cysteines, and residue 6 is Ala and residue
111 is Ser in these organisms (16). More evolved organisms,
such as flies, fishes, andmammals, including the Japanesemon-
key, have only one free cysteine, Cys6. Only humans and great
apes (chimpanzee and orangutan) have two free cysteines, Cys6
and Cys111 (17). Notably, the amino acid sequence of chimpan-
zee SOD1 is identical to that of human SOD1. Although the
evolutionary process may differ from humans and great apes,
chicken SOD1 has three free cysteines, including Cys6 and
Cys111. The third free Cys residue is located at the C terminus,
Cys154 (18). Because free cysteines are generally reactive, and
wild-type SOD1 is less thermo-stable than Ser111-SOD1 or
Ala6-SOD1 (19), the A6C and S111C mutations during evolu-
tion are puzzling. In particular, Cys111 is located at the surface
of the SOD1 molecule and is thought to be highly reactive. De
Beus et al. (20) reported that Cys111 was modified with persul-
fide (S-SH) in a human SOD1 isolated from erythrocytes that is
commercially available (Sigma). The persulfide SOD1 was
more resistant to copper-induced aggregation than wild-type
SOD1 (20). The sulfur atomof cysteine is able to assume several
different oxidation states. Reversible oxidation of cysteine to
disulfide (-S-S-) or sufenic acid (-SOH) is readily accomplished
by thiols, such as DTT, 2-ME, glutathione, or thioredoxin. In
contrast, oxidation to sulfinic acid (-SO2H) or sulfonic acid
(-SO3H) is not reduced by these thiols under physiological con-
ditions (21). For example, one cysteine in the active site of per-
oxiredoxin (Prx) is oxidized to sulfinic acid (-SO2H) by incuba-
tion with an excess of substrate of this enzyme, H2O2, and
rereduced by a specific enzyme, sulfiredoxin, but not by general
thiols (22, 23).
Anupper shifted bandof humanwild-type ormutant SOD1s,
with the exception of mutant C111S, on SDS-PAGE has been
observed under a variety of conditions: during purification (24)
or when hydrogen peroxide or copper ion is added (see Fig. 1).
The SOD1 in the upper band is speculated to be irreversibly
linked to another molecule via a covalent bond at Cys111; how-
ever, neither the molecule nor the modification site have been
identified. Ube Industries Ltd. developed recombinant human
SOD1 chemically modified with 2-mercaptoethanol at Cys111
(2-ME-SOD1; Cys111-S-S-CH2CH2OH). This 2-ME-SOD1 is
stable formany years in aqueous solution, showing neither deg-
radation nor a loss of activity. Thus, in this study, the role of
Cys111 in oxidative damage of human SOD1was investigated by
comparing 2-ME-SOD1 and wild-type SOD1, and the identity
of the molecule that is bound to human SOD1 in the upper
band on SDS-PAGEwas explored. Throughmass spectrometry
and limited proteolysis, it was determined that the mass size of
the molecule is 32 and 48 and that the modification site in
SOD1 is Cys111. We demonstrated that Cys111 in human SOD1
is selectively oxidized to cysteine sulfinic acid (Cys-SO2H) and
to cysteine sulfonic acid (Cys-SO3H) even by air oxidation.
Moreover, a polyclonal antibody was raised against a synthe-
sized peptide containing Cys111-SO3H. This antibody, denoted
as anti-C111ox-SOD1, reacted with the upper band (oxidized
SOD1) but not the original band by Western blot analysis.
Using this anti-C111ox-SOD1, the role of Cys111 on the gener-
ation of SOD1 charge isomers and the presence of oxidized
SOD1 in the spinal cord of ALS mice were investigated.
EXPERIMENTAL PROCEDURES
Materials—All chemicals used in this study were obtained
either from Wako Pure Chemical Industries Ltd. (Osaka,
Japan), Nacalai Tesque, Inc. (Kyoto, Japan), or Sigma unless
specified otherwise. Recombinant human SOD1, chemically
modified with 2-mercaptoethanol (2-ME-SOD1), was kindly
provided from Ube Industries Ltd. Horseradish peroxidase-
conjugated goat anti-rabbit IgG and horseradish peroxidase-
conjugated rabbit anti-goat IgG were purchased from Dako
(Denmark). Lysylendopeptidase (Achromobacter Proteinase I)
was obtained from Wako Pure Chemical Industries Ltd.
(Osaka, Japan). Sequencing grade modified trypsin was pur-
chased from Promega (Madison, WI). Sinapinic acid and
-cyano-4-hydroxycinnamic acid for matrix of MALDI-
TOF MS were obtained from Bruker Daltonik GmbH (Bre-
men, Germany).
Conversion of 2-ME-SOD1 toWild-type SOD1—2-ME-SOD1
was incubatedwith 20mM2-ME for 1 h on ice and desaltedwith
a PD-10 column. The resultant wild-type SOD1 and 2-ME-
SOD1 were used in the experiments with the exception of the
experiments in Fig. 1, B and C.
Production and Purification of Wild-type and Mutant SOD1
Proteins—Overproduction of SOD1s by the baculovirus/insect
cells system and purification of SOD1 proteins were carried out
as described previously (25).
Oxidation of SOD1 and the Analyses with MonoQ Column—
For strong oxidation, SOD1s diluted with miliQ water (1
mg/ml) were incubated with 5 mM H2O2 for 1 h at room tem-
perature. For mild air oxidation, SOD1s diluted with miliQ
water or appropriate buffer were filtered with a 0.22-m filter
(Millipore) and were slowly stirred at 30 rpm with a rotator
(rotator RT-50; Taitec). The buffer or water containing oxi-
dized SOD1swas changedwith bufferA (2mMpotassiumphos-
phate, pH 7.4) on a PD-10 column (Amersham Biosciences).
The SOD1s were applied to a high performance liquid chro-
matograph (AKTA Explorer 10S) at a flow rate of 1 ml/min on
a MonoQ column (MonoQTM 4.6/100 PE; Amersham Bio-
sciences). After washingwith buffer A, the bound proteinswere
eluted with a linear gradient of KCl (0–100 mM) in buffer A.
Adhesive proteins were washed with 0.5 M KCl in buffer A.
Lysylendopeptidase Treatment and Peptide Analyses—SOD1
proteins were reduced with DTT, and the free sulfhydryls were
carbamidemethylated by adding iodoacetamide (IA) in the dark
at room temperature for 30 min. After desalting on a PD-10
column with 50 mM Tris-HCl (pH 8.8), the proteins were
digested with 0.25% (w/w) lysylendopeptidase (Wako Pure
Chemicals) at 37 °C for 16 h. The resultant peptides were
applied to a reverse-phase high performance liquid chromato-
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graph (AKTA Explorer 10S) at a flow rate of 1 ml/min on TSK-
GEL ODS-80TM (4.6  250 mm; Tosoh). The peptides were
separated by two linear gradients of 0–30% acetonitrile for 4
column volumes and 30–40% acetonitrile for 8 column vol-
umes containing 0.05% trifluoroacetic acid. Peptides were
detected by their absorbance at 215 nm. The peaks were sub-
jected to the following MS analyses.
MALDI-TOF MS Analysis—MALDI-TOF MS spectra of
peptides and proteins were measured on an Ultraflex TOF/
TOF mass spectrometer and analyzed by the Flexcontrol 1.2
software package (Bruker Daltonics GmbH, Bremen, Ger-
many). For analyses of peptides, ions generated by a pulsed UV
laser beam (nitrogen laser;  337 nm, 5 Hz) were accelerated
to a kinetic energy of 20 kV in reflector mode using positive
polarity.Metastable ions generated by laser-induced decompo-
sition of the selected precursor ions were analyzed without any
additional collision gas. -Cyano-4-hydroxycinnamic acid (5
mg/ml in 50% acetonitrile containing 0.1% trifluoroacetic acid)
was used as a matrix for peptide analyses. For analyses of pro-
teins, the determinations were performed in linear mode using
positive polarity. Sinapinic acid (10 mg/ml in 50% acetonitrile
containing 0.1% trifluoroacetic acid) was used as matrix for
protein analyses. Peptide or protein samples (1 l each) were
mixed with matrix solution (4 l each), and an aliquot (1 l
each) was applied to a polished stainless steel target (Bruker
Daltonics). The mixture was dried in air at room temperature
for several minutes.
Infusion ESI MS Analysis for Peptide Sequence—ESI mass
spectraweremeasured on aBruker EsquireHCTequippedwith
a quadrupole ion trap (Bruker Daltonics GmbH, Bremen, Ger-
many). The solutions containing peptides digested with
lysylendopeptidase were continuously introduced through the
electrospray interface with a syringe infusion pump (Cole-
Parmer, Vernon Hills, IL) at a flow rate of 5 l/min. The MS
conditions were as follows: nebulizer gas (N2), 10 p.s.i.; dry gas
(N2), 4 liters/min; dry temperature, 250 °C; capillary voltage,
3500 V; high voltage end plate offset, 500 V; capillary exit,
190.6 V; skimmer, 40 V; trap drive, 166.7. MS/MS spectra were
sequenced using BioTool 2.2 software and Sequence editor 2.2
(algorithm provided by Bruker).
TrypsinDigestion forMALDI-TOFMS—SOD1proteins in 50
mMNH4HCO3 were digested with trypsin at 37 °C for 16 h. An
aliquot of the digests (10 l) was boiled, applied to ZipTip C18
P10 (Millipore, Bedford, MA; according to the manufacturer’s
protocol) for desalting, and then subjected toMALDI-TOFMS
analysis. When alkylation is needed, SOD1 proteins in 50 mM
NH4HCO3 were treated with excess IA in the dark at room
temperature for 30 min before trypsin digestion.
In-gel Digestion of Coomassie Brilliant Blue-stained Poly-
acrylamide Gel for MALDI-TOF MS—The gel bands contain-
ing SOD1 protein after SDS-PAGE were clipped out and cut
into small pieces in a 1.5-ml microtube. To remove Coomassie
Brilliant Blue dye, the chopped gels were washed three times
with 50 mM NH4HCO3 in 30% acetonitrile by shaking at room
temperature for 20 min. The gels were further incubated with
500 l of acetonitrile at room temperature for 10 min. After
removing acetonitrile, the gels were incubated with an alkylat-
ing solution (500l) consisting of 40mM IA, 10mM EDTA, and
50 mM NH4HCO3 in the dark at room temperature for 30 min.
After washing twice with 50mMNH4HCO3 (500l) for 10min,
the gels were incubated with 0.4 g of trypsin in 50 mM
NH4HCO3 at 37 °C overnight. After removing the pieces of
gels, the remained solution was concentrated with a SpeedVac
concentrator and subjected to MALDI-TOF MS analyses.
Preparation of Antibody for Cys111-sulfonylated SOD1—Key-
hole limpet hemocyanin-coupled peptide (residues 103–114)
containing sulfonylated Cys111 (Cys111-SO3H) was obtained
from Sigma. After the initial injection with the peptide-hemo-
cyanin conjugate (200 g of peptide) mixed with complete
Freund’s adjuvant, rabbits were subjected to five booster injec-
tions, each of 200g of peptide with incomplete Freund’s adju-
vant, administered (at multiple subcutaneous sites) at
1–2-week intervals. Antisera were collected 1 week after the
sixth booster injection, and the IgG fraction was precipitated
with 50% (w/v) ammonium sulfate. The IgG fraction passed
from the wild-type SOD1 coupled to N-hydroxysucinimide-
activated Sepharose was bound to the oxidized SOD1 coupled
to N-hydroxysucinimide-activated Sepharose. The bound IgG
was eluted with 3 MMgCl2 and collected. The IgG was desalted
with a PD-10 column and stored with 0.1 mg/ml bovine serum
albumin (BSA) at deep freeze until use. This antibody was
denoted as anti-C111ox-SOD1.
SDS-PAGE and Western Blot Analysis—Proteins were sub-
jected to SDS-PAGE (14% gel) and then transferred to a PVDF
membrane under semidry conditions by means of a Trans-blot
(Bio-Rad). After blocking by incubation with 5% skim milk in
Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 8.0, 0.15 M
NaCl) for 2 h at room temperature, the membrane was incu-
bated with anti-C111ox-SOD1 (diluted 1:1000), or a goat poly-
clonal antibody against full-length human SOD1 (25), anti-
SOD1 (diluted 1:1000), in TBS containing 0.05% Tween 20
(TBS-T) and 1% skim milk for 2 h at room temperature or for
18 h at 4 °C. After washing with TBS-T, the membrane was
incubated with horseradish peroxidase-conjugated anti-rabbit
IgG (diluted 1:5000) for anti-C111ox-SOD1or horseradish per-
oxidase-conjugated anti-goat IgG (diluted 1:5000) in TBS-T
containing 1% skim milk for anti-SOD1, respectively, for 2 h at
room temperature. After washing, the chemiluminescence
method using an ECL or an ECL plus kit (GE Healthcare) was
employed to detect peroxidase activity.
Two-dimensional Gel Electrophoresis—Sample proteins
were dissolved in 8 M urea, 2% (w/v) CHAPS, 0.5% (v/v) immo-
bilized pH gradient (IPG) buffer (GE Healthcare), and 12 l/ml
DeStreakTM reagent (GEHealthcare), which forms stable disul-
fide bonds and prevents nonspecific Cys residue oxidation dur-
ing isoelectric focusing (26). The samples were applied to
11-cm IPG strips (pH 4–7), and the strips were then isoelectri-
cally focused on an IPGphor isoelectric focusing system (GE
Healthcare) according to the following schedule: 500V-h at 500
V for step and hold, 800 V-h at 1000 V for gradient, 8800 V-h at
6000 V for gradient, and 4000 V-h at 6000 V for step and hold.
The strips were equilibrated for 20 min in 50 mM Tris-HCl (pH
8.8) containing 6 M urea, 2% (w/v) SDS, 30% (v/v) glycerol, and
1% (w/v) DTT. Second dimension separation was run on 14%
SDS-polyacrylamide gels and followed by Western blot analy-
sis. pI values of spots were calculated according to the graph
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showing pH as function of distance at 20 °C and 8 M urea of IPG
strips (pH 4–7) provided by the GE Healthcare on-line system.
ELISA—Wild-type SOD1 was air-oxidized, treated with and
without 100 mM IA, and then diluted to 500 ng/ml with phos-
phate-buffered saline (PBS). 100 l of the samples were added
to each well of 96-well microplates (Maxisorp; Nunc), incu-
bated overnight at 4 °C, washed three times with TBS-T, and
then blocked for 2 h at room temperature with 1% BSA in PBS.
The plates were then washed three times with TBS-T, and 100
l of anti-C111ox-SOD1 and anti-SOD1 antibodies (diluted
1:1000 in TBS-T) was added, followed by incubation for 1 h at
room temperature. The plates were washed three times with
TBS-T, and 100 l of horseradish peroxidase-conjugated anti-
rabbit IgG (diluted 1:5000 in TBS-T) for anti-C111ox-SOD1 or
horseradish peroxidase-conjugated anti-goat IgG (diluted
1:5000 in TBS-T) for anti-SOD1, respectively, was added and
incubated for 1 h at room temperature. Afterwashing five times
with TBS-T, the plates were developed using 100 l of o-phe-
nylenediamine dihydrochloride solution, and the reaction was
stopped with 25l of 2 MHCl. The absorbance of each well was
determined at 490 nm with a SPECTRAmax PLUS384 (Molec-
ular Devices).
Animals and Animal Tissue Preparation—Four transgenic
mice carrying a high copy number of the human G93A SOD1
gene (B6SJL-TgN[SOD1-G93A]1Gur, G1H-G93A) mice, were
purchased from the Jackson Laboratory (BarHarbor,ME). Two
age-matched littermates were used as controls. All animals
were handled in accordancewith the guidelines for care and use
(Tottori University). All four G1H-G93A mice at 110 days of
age neurologically exhibited hind limb paralysis, and two litter-
mate mice at 110 days of age did not show any clinical symp-
toms. The G1H-G93A and littermate mice were euthanized at
110 days of age. Animals were deeply anesthetized with sodium
pentobarbital (0.1 ml/100 g of body weight). After perfusion of
three G1H-G93A and two littermate mice via the aorta with
PBS at 37 °C, they were fixed by perfusion with 4% paraformal-
dehyde in 0.1 M cacodylate buffer (pH 7.3). The spinal cords
were removed and then postfixed in the same solution. The
spinal cord of one mouse for Western blot analysis was
removed after perfusion with PBS, quickly frozen in liquid
nitrogen, and stored at80 °C until use.
Protein Extraction from G1H-G93A Mouse Spinal Cord—
The G1H-G93A spinal cord was homogenized in ice-cold
homogenization buffer, 20 mM Tris-HCl (pH 6.8) containing
CompleteTM miniprotease inhibitor mixture (Roche Applied
Science), and 100 mM IA for preventing the secondary oxida-
tion of SH groups. The sample was centrifuged at 17, 000 g at
4 °C for 30 min, and the pellet was homogenized in the ice-cold
homogenization buffer containing 1% Triton X-100. The sam-
ple was centrifuged at 17,000  g at 4 °C for 30 min, the pellet
was further homogenized in the ice-cold homogenization
buffer containing 1%Triton X-100 and 2% SDS, and the sample
was centrifuged at 17,000 g at 4 °C for 30 min. The superna-
tants of each homogenization, buffer-soluble, Triton X-100-
soluble, and SDS-soluble fractions, were subjected to SDS-
PAGE and Western blot analyses.
Immunohistochemical Analysis—After fixation, the speci-
mens were embedded in paraffin, cut into 5-m-thick sections,
and examined for immunohistochemical analysis. Sections
were deparaffinized and then washed in PBS. Normal serum
homologous with the secondary antibody diluted in 1% BSA-
containing PBS (BSA-PBS) was used as a blocking reagent. Tis-
sue sections were incubated with anti-C111ox-SOD1 (diluted
1:1000 in BSA-PBS) at 4 °C for 18 h. Bound antibody was visu-
alized by the avidin-biotin-immunoperoxidase complex (ABC)
method using the appropriate Vectastain Elite ABC rabbit IgG
kit (Vector Laboratories) and 3,3-diaminobenzidine tetrahy-
drochloride (Wako, Osaka, Japan) as a chromogen. The endog-
enous peroxidase activity was quenched by incubation for 30
min with 3% H2O2 after the secondary antibody treatment to
prevent nonspecific oxidation before anti-C111ox-SOD1
treatment.
SOD1 Activity—SOD1 activity was assayed using the xan-
thine-xanthine oxidase/cytochrome c system as described pre-
viously (27).
Protein Assay—SOD1 protein concentrations were esti-
mated using a dimeric molar extinction at 280 nm of 10,800
M1 cm1 (28). Protein concentrations of crude samples were
determined using a BCATM protein assay kit (Pierce) with BSA
as a standard.
RESULTS
2-ME-SOD1 Obtained from Ube Industries Ltd. Was Modi-
fied with 2-ME Only at Cys111—First, the chemical modifica-
tion with 2-mercaptoethanol of recombinant human Cu/Zn-
SOD (2-ME-SOD1) was confirmed. The molecular mass of
2-ME-SOD1 was determined to be 15,865.5 (supplemental Fig.
S1A) to 15,871 m/z (supplemental Fig. S2A), which suggested
the presence of 2-ME (76 Da) in apo-human SOD1 (monoiso-
topic mass, 15,794.86; average mass, 15,804.55). The metals,
copper and zinc, of SOD1 were removed during MALDI-TOF
MS analysis. Since this recombinant human SOD1 was
expressed in Escherichia coli, the N terminus was not acety-
lated. To demonstrate that the 2-ME-SOD1 was in fact modi-
fied with 2-ME only at Cys111, the 2-ME-SOD1 was digested
with trypsin and then analyzed by MALDI-TOF MS and
MS/MS. The mass of the tryptic peptide (2533m/z) indicating
residues Asp92–Arg115 (2457 m/z) plus the mass of 2-ME (76
Da) (supplemental Fig. S1B) was analyzed by the collision-in-
duced MS/MS. As shown in supplemental Fig. S1C, the major
fragment ions, y4 (457.1 m/z), y5 (635.9 m/z), y6 (772.9 m/z),
y14 (1530.9m/z), y19 (2074.4m/z), and y23 (2418.7m/z), indi-
cated the presence of 2-ME at Cys111. The mass of the tryptic
peptide (933 m/z, missed cleavages  1), residues Ala1–Lys9,
indicated that another free cysteine, Cys6, was not modified
with 2-ME (supplemental Fig. S1B). MS/MS analyses of the
residues Ala1-Lys9 also indicated that 2-ME was not contained
in this peptide (supplemental Fig. S1D). These results demon-
strated that Cys111, but not Cys6, was modified with 2-ME. The
commercial human SOD1 from Sigma, modified with persul-
fide (S-SH) or with trisulfide (-S-S-S-) intersubunit linkage at
Cys111, exhibits an absorbance peak at 325 nm (20, 29). How-
ever, 2-ME-SOD1 did not exhibit the 325 nm peak (data not
shown).
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Additional 2-ME Treatment Recovered the 2-ME-SOD1 to
Wild-type SOD1—Next, the ability to remove 2-ME from
Cys111 was examined. 2-ME-SOD1 was incubated with 0
(H2O), 2, 20, and 200 mM 2-ME for 1 h on ice; the excess 2-ME
was removed on a PD-10 column with miliQ water, and then
themass of the proteins was analyzed. As shown in supplemen-
tal Fig. S2A, the incubation with more than 20 mM 2-ME
decreased the mass of the protein (from 15,871 to 15,795m/z).
The difference in the mass was 76 m/z, indicating that incuba-
tion with 20 mM 2-ME removes 2-ME from Cys111. Thus, to
confirm this finding, the 2-ME-treated SOD1s were digested
with trypsin after incubation with IA, and the mass of the
resulting peptides was determined. Removal of 2-ME from
Cys111, would allow the SH group of Cys111 to be carbamidem-
ethylated by IA, yielding a mass of 2514 (2456 plus 58)m/z. As
shown in supplemental Fig. S2B, themass of the tryptic peptide
containing Cys111 (residues Asp92–Arg115) treated with more
than 20 mM 2-ME was 2514 m/z. In contrast, the mass of the
2-ME-SOD1 treated with H2O was 2533 m/z, indicating that
the SH group of Cys111 remained bound to 2-ME. These results
show that incubation of 2-ME-SOD1with 2-ME in excess of 20
mM removed 2-ME from Cys111, converting 2-ME-SOD1 to
wild-type SOD1. The SOD activities of 2-ME-SOD1 and the
wild-type SOD1 were 4181 and 4056 units/mg, respectively,
indicating that both SOD1s have similar activities.
Upper Band of Oxidized Human SOD1 on SDS-PAGE
Involves Cys111—2-ME-SOD1 and wild-type SOD1 were incu-
bated with various concentrations of H2O2 for 20min and then
subjected to reducing SDS-PAGE. Although 2-ME-SOD1 was
slightly affected byH2O2 treatment, wild-type SOD1 showed an
additional upper band when incubated with more than 1 mM
H2O2 (Fig. 1A). When commercial gradient gels (5–20%, e-
PAGEL; Atto) were used for the SDS-PAGE, the upper band
was not observed (data not shown). It is thought that the two
bands are unable to separate on the gradient gels. Next, various
purified wild-type and mutant human SOD1 proteins
expressed in the baculovirus/insect cell system (25) were oxi-
dized with 1 mM H2O2, followed by reducing SDS-PAGE and
Western blotting. As shown in Fig. 1B, the additional upper
band appeared in all SOD1s, exceptC111S, after oxidation. Fur-
thermore, the effects of various metal ions on the generation of
the upper bandwere investigated.Only theCu2 ion, among all
metal ions examined, formed an upper band similar to that
observed after oxidation with H2O2 (Fig. 1C). Although Fe3
and Fe2 are thought to be oxidants, neither Fe3 (data not
shown) nor Fe2 treatment generated the upper band. Next,
wild-type SOD1 diluted with various pH buffers was slowly
stirred (30 rpmwith a rotator) for 24 h at room temperature. As
shown in Fig. 1D, the upper bandwas generatedwhen the pHof
the incubation buffer was higher than pH 7. These results indi-
cated that Cys111 was readily oxidized by oxygen in ambient air
and that the sulfhydryl group (SH) of Cys111 was needed to
provide a thiolate anion (S) for the oxidative modification.
Role of Cys111 in the Generation of Negatively Charged Mole-
cules after Oxidation—To examine the role of Cys111 in the
generation of negatively charged molecules after oxidation,
2-ME-SOD1 and wild-type SOD1 were incubated with 5 mM
H2O2 for 1 h andwere applied to aMonoQcolumn. Some of the
fractions were then subjected to reducing SDS-PAGE and
Western blotting. Since incubation with 5 mM H2O2 caused
oxidation of almost all histidine and cysteine residues in bovine
SOD1 (3), it is thought that negatively charged molecules were
generated in both SOD1s. As shown in the upper panels of Fig.
2, A and B, several peaks containing oxidized SOD1 proteins
were eluted with similar patterns in both SOD1s. However, the
results ofWestern blotting were quite different (lower panels in
Fig. 2, A and B). In oxidized 2-ME-SOD1, only one fragment
(labeled with an asterisk) from the first peak and slight polymer
bands from the last fractions, which were obtained by washing
the column with 0.5 M KCl, were observed (Fig. 2A). The single
fragment resulting from oxidation of 2-ME-SOD1 has been
identified by Ookawara et al. (5) as a large fragment cleaved
between Pro62 and His63. Because Ookawara et al. (5) also used
recombinant human SOD1 (2-ME-SOD1) obtained from Ube
Industries Ltd., it can be concluded that the identity of the sin-
gle fragment in the present study and that ofOokawara et al. (5)
FIGURE 1.Generation of upper shifted bandof SOD1on SDS-PAGEunder
reducing conditions. A, 2-ME-SOD1 and wild-type SOD1 treated with vari-
ous concentrations of H2O2 for 20 min, diluted with miliQ water, and boiled
with SDS-PAGE loading buffer containing 5% 2-ME. 5 g of protein/lane was
subjected to SDS-PAGE (14% gel). RainbowTM colored protein molecular
weight markers purchased from GE Healthcare were used as molecular
weightmarkers (left).B,Westernblot analyses ofwild-type andmutant SOD1s
treatedwith1mMH2O2 for 20min.C,Westernblot analysesofwild-typeSOD1
treated with 1 mM CuCl2, ZnCl2, MnCl2, FeCl2, CoCl2, NiSO4, MgCl2, and H2O2
for 1 h. Wild-type and mutant SOD1s used in B and C were produced by the
baculovirus/insect cells system. SOD1 proteins in B and C were immuno-
stained with anti-SOD1. D, SDS-PAGE of wild-type SOD1 stirred for 24 h in
various pH buffers (50 mM), citric acid-NaOH (pH 3.0), sodium citrate-diso-
dium phosphate-NaOH (pH 5.0), sodium phosphate (pH 7.0), and glycine-
NaOH (pH 9.0 and 11.0). The arrowheads with solid lines indicate SOD1 sub-
units, and arrowheadswith broken lines indicate modified SOD1 subunits.
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are the same. In contrast, oxidation of the wild-type SOD1
resulted in not only the upper band but also in several addi-
tional fragments and polymer bands (Fig. 2B). Oxidation of
Cys111 may become a trigger of fragmentation and polymeriza-
tion. Zhang et al. (8) reported that a covalently cross-linked
dimer (polymer) of human SOD1 was induced by bicarbonate
and H2O2. Therefore, the effects of bicarbonate on the oxida-
tion of 2-ME-SOD1 and wild-type SOD1 were investigated.
However, no difference in dimer formation between the two
SOD1 variants was observed (data not shown), suggesting that
the cross-linkage between monomers was not mediated by
Cys111.
Identification of the Molecule in the Upper Band—Next, the
identity of the molecule in the upper band was explored. Slow
stirring in miliQ water did not cause fragmentation and poly-
merization of SOD1 but generated the upper band. Thus, in
order to exclude effects of the buffer system, 2-ME-SOD1 and
wild-type SOD1 were oxidized by stirring in miliQ water. Then
themolecularmasses weremeasured byMALDI-TOFMS. The
air-oxidized wild-type SOD1 showed two masses, 15,792 and
15,838 m/z, but the mass of 2-ME-SOD1 did not change (Fig.
3A). Fig. 3B shows the elusion patterns of air-oxidized 2-ME-
SOD1 and wild-type SOD1 on theMonoQ column. The stirred
wild-type SOD1 (solid line) was separated into two peaks (a and
b), whereas the stirred 2-ME-SOD1 (dotted line) was not sepa-
rated. MALDI-TOF MS also showed that the SOD1 protein in
peak b also gave two masses, 15,793 and 15,841 m/z (Fig. 3C),
and gave two bands on reducing SDS-PAGE (Fig. 3D). It is note-
worthy that the SOD activity in peak b (3716 units/mg) was
similar to the activity in peak a (3753 units/mg) and that SOD1
proteins in both peaks retained more than 90% of SOD activity
compared with the original wild-type SOD1. These results sug-
gested that oxidative modification at Cys111 did not affect on
SOD activity and that His residues in the active site were still
intact. The difference in mass units between the SOD1 subunit
in the upper band and the SOD1 subunit in the original band
appeared to be about 48, suggesting
the presence of three oxygens at
Cys111. Next, the upper and original
bands from reducing SDS-PAGE
(Fig. 3D) of peak b from theMonoQ
column were clipped out, alkylated
with IA, and digested with trypsin.
The resultant peptides were sub-
jected toMALDI-TOFMS analyses.
In the upper band, a major mass,
2505 m/z, corresponding to tryptic
peptide 92–115 (2457 m/z) plus 48
was detected. A minor mass, 2489
m/z, corresponding to tryptic pep-
tide 92–115 plus 32 was also
observed (Fig. 3E). In contrast, in
the original band, a mass of 2514
m/z resulting from carbamidem-
ethylation (plus 58) of tryptic pep-
tide 92–115 was detected (Fig. 3F).
These results indicate that amino
acids in residues 92–115, probably
Cys111, in the upper band, were oxidized with two or three
molecules of oxygen (Cys111-SO2H or Cys111-SO3H). However,
the amounts of these peptides were too small for MS/MS anal-
yses to determine the amino acid sequence.
To obtain greater quantities of oxidized peptides, SOD1 pro-
teins in peaks a and b separated with the MonoQ column (Fig.
3B) were reduced by DTT, alkylated with IA, and digested with
lysylendopeptidase, but not with trypsin. The resultant pep-
tides were applied to a reverse-phase high performance liquid
chromatograph (ODS column). As shown in Fig. 4A, the HPLC
elution profiles were nearly identical, but two additional peaks
(d and e) were observed after the last peak (c) only in digests
from peak b of theMonoQ column (i.e. the lower panel). Peak c
has already been identified as residues 92–122 containing car-
bamidemethylated Cys111 in previous work (25). When frac-
tions containing the additional peaks d and e were reapplied to
the ODS column, four fractions containing three distinct peaks
were obtained (Fig. 4B). Each fractionwas subjected toMALDI-
TOF MS analyses. As a result, peptide c in fractions 1 and 2
corresponded to residues 92–122 containing carbamidemethy-
lated Cys111 (3320.5m/z), as expected. Peptide d, in fractions 2
and 3, and peptide e, in fractions 3 and 4, gave masses corre-
sponding to residues 92–122 plus 32 (3295.5m/z) and residues
92–122 plus 48 (3311.6m/z), respectively (Fig. 4C).
To directly demonstrate the formation of Cys111-SO2H and
Cys111-SO3H, these peptides (c–e), were further analyzed by
infusionESIMS/MS.Thismethodwas used to ascertain the site
of oxidative modification of SOD1 by determination of the
amino acid sequence of the peptides. The amino acid sequence
of the peptide 92–122was determined based on the assumption
that Cys111 was modified with carbamidemethyl (Fig. 5B),
sulfinic acid (SO2H) (Fig. 5C), and sulfonic acid (SO3H) (Fig.
5D), respectively. The mass of peptide c (3320.5m/z), Cys-car-
bamidemethyl ([M 2H]2 1661.2m/z) gave themajor frag-
ment ions, y5 (611.3 m/z), y10 (1152.0 m/z), y12 (1424.6 m/z),
y13 (1561.7 m/z), and y21* ([M  2H]2  1161.0 m/z), indi-
FIGURE 2. Separation of oxidized SOD1s with a MonoQ column. 2-ME-SOD1 and wild-type SOD1 were
incubated with 5 mM H2O2 for 1 h and were applied to a MonoQ column; some fractions were subjected to
reducing SDS-PAGE and Western blot analyses. A, chromatogram profiles of oxidized and intact 2-ME-SOD1
separated with MonoQ column (top), and Western blot analysis of some fractions indicated (bottom). B, chro-
matogram profiles of oxidized and intact wild-type SOD1 separated with MonoQ column (top), and Western
blot analysis of some fractions indicated (bottom). SOD1 proteins in A and B were immunostained with anti-
SOD1. The arrowheads with solid lines indicate SOD1 subunits, and arrowheads with broken lines indicate
modified SOD1 subunits.mAU, milliabsorbance units.
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cating that Cys111 was carbamidemethylated, as expected (Fig.
5E). Themass of peptide d (3295.5m/z) ([M 2H]2 1648.3
m/z) gave the major fragment ions, y11 (1264.6, m/z), y12
(1399.7 m/z), y13 (1536.7 m/z), and b20 (2031.6 m/z), which
was identified to be residues 92–122 containing Cys111-SO2H
(Fig. 5F). Furthermore, the mass of peptide e (3311.6 m/z)
([M  2H]2  1657.2 m/z) gave the major fragment ions, y9
(1038.6 m/z), y12 (1415.6 m/z), y13 (1552.7 m/z), y18 (2012.0
m/z), and y21 (2310.8m/z), indicating that Cys111 was oxidized
to Cys-SO3H (Fig. 5G). Analyses based on the assumption that
His110 and/or His120 were oxidized to 2-oxo-histidine showed
that the corresponding y ions and b ions were absent (data not
shown). These results clearly indicated that Cys111 was readily
oxidized to Cys-SO2H, which underwent further oxidation to
Cys-SO3H without His oxidation by air, and that the peroxida-
tion of SOD1 atCys111 resulted in the upper band shift in reduc-
ing SDS-PAGE.
Anti-C111ox-SOD1 Recognized Only Cys111-peroxidized
SOD1—To explore the possibility of immunological detection
of Cys111-peroxidized SOD1 (Cys111-SO3H-SOD1), a rabbit
polyclonal antibody against the peptide containing Cys111-
SO3Hwas prepared. The antiserumwas purified to exclude the
reactivity with reduced form SOD1 (Cys111-SH) by affinity col-
umns as described under “Experimental Procedures.” The
resultant IgG, which was denoted as anti-C111ox-SOD1,
reacted with only the upper band of Cys111-peroxidized SOD1
but neither the original band of wild-type SOD1 nor 2-ME-
SOD1 (Fig. 6A). These data further demonstrated that the
upper band is the oxidized form of SOD1 containing sulfony-
lated Cys111. Also, in ELISA experiments, the anti-C111ox-
SOD1 specifically reacted with IA-treated air-oxidized wild-
type SOD1, but neither with 2-ME-SOD1 nor with IA-treated
wild-type SOD1 (Fig. 6B). However, when wild-type SOD1 was
not treated with IA before ELISA, the wild-type SOD1 was also
reacted with anti-C111ox-SOD1, indicating that SH of Cys111
of the wild-type SOD1 was oxidized during coating on the
96-well plate.
Two-dimensional Gel Electrophoresis Characterization of
Oxidized SOD1—It is well known that human, bovine, and
recombinant human SOD1 proteins have several charge iso-
mers detected byHPLC, isoelectric gel focusing, or two-dimen-
sional gel electrophoresis (26, 30, 31). The reason for the heter-
ogeneity is still unknown, although some hypotheses, such as
differentmetallation, different conformation, and different oxi-
dation of Cys residues, were presented (13, 26). Thus, two-di-
mensional gel electrophoresis of oxidized SOD1was performed
FIGURE 3.Analyses of upper and original bands on SDS-PAGE. A, MALDI-TOFMS spectra of intact and stirred 2-ME-SOD1 andwild-type SOD1, respectively.
B, chromatogram profiles of stirred wild-type SOD1 and 2-ME-SOD1 on a MonoQ column. C, MALDI-TOF MS spectra of SOD1 in peaks a and b, separated with
a MonoQ column (B). D, SDS-PAGE of intact (i) and stirred (s) 2-ME-SOD1 and SOD1s in peaks a and b. The arrowheadswith solid lines indicate SOD1 subunits,
and arrowheads with broken lines indicate modified SOD1 subunits. Precision Plus protein standards purchased from Bio Rad were used for the molecular
weight marker (left side). E and F, MALDI-TOF MS spectra of tryptic peptides (residues Asp92–Arg115) from the upper band (E) and the original band (F),
respectively, in the right lane of D.mAU, milliabsorbance units.
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to examine the effects of Cys111 oxidation on the generation of
charge isomers. As shown in Fig. 7A, wild-type SOD1presented
the main spot 3 (pI 5.15) and three tiny spots, 1 (pI 4.92), 2 (pI
5.02), and 4 (pI 5.8). 2-ME-SOD1 also presented four similar
spots (Fig. 7B). Three of them, spots 1–3, were thought to cor-
respond to three isomers of recombinant human SOD1 with pI
of 4.99, 5.06, and 5.14, which was
previously determined by isoelec-
tric gel electrophoresis (30). When
2-ME-SOD1 was oxidized by H2O2,
three major spots, 5 (pI 5.32), 6 (pI
5.52) and 7 (pI 5.65), were newly
generated between spots 3 and 4
(Fig. 7C). In contrast, when wild-
type SOD1 was oxidized by H2O2,
further new spots, 5 (pI 5.3), 6 (pI
5.46), and 7 (pI 5.6), which were
probably their upper and acidic
shifted spots of the spots 5 (pI 5.32),
6 (pI 5.52), and 7 (pI 5.65), respec-
tively, were generated (Fig. 7, D and
E). Furthermore, twomajor spots, 1
and 2, and weak spot 3, just above
spots 1, 2, and 3, respectively, were
also detected by anti-C111ox-SOD1
(Fig. 7E). Air oxidation of wild-type
SOD1 generated only the twomajor
spots, 1 and 2, and one tiny spot, 7
(Fig. 7, F and G). Therefore, these
results indicated that spots 1, 2,
and 7 were generated by the oxida-
tion of Cys111 and that the genera-
tion of spots 5, 6, and 7 (Fig. 7C) was
caused by the oxidation of other
amino acid residues.
Cys111-peroxidized SOD1 Was
Detected in Spinal Cord of G1H-
G93AMice—Because this new anti-
body, anti-C111ox-SOD1, is a good
tool for detection of Cys111-peroxi-
dized SOD1, G1H-G93A mouse
spinal cord extract was subjected to
Western blot analysis to examine
the involvement of oxidized SOD1
in ALS. The anti-C111ox-SOD1
clearly reacted with the 25 kDa
band in the Triton X-100-soluble
fraction (Fig. 8A, left). Although
someweak bandswere detected, the
upper band of oxidized SOD1 was
not detected in all fractions. Im-
munostaining with anti-SOD1
detected a large amount of human
SOD1 overexpressed in the G1H-
G93Amouse andmouse SOD1 (Fig.
8A, right). In contrast, anti-C111ox-
SOD1 detected the upper band of
oxidized SOD1 (positive control)
but neither the reduced form of G93A-SOD1 nor mouse SOD1
(Fig. 8A, left). Therefore, the 25 kDa band, selectively recog-
nized by anti-C111ox-SOD1, was thought to be some mole-
cule-bound oxidized SOD1. Basso et al. (26) detected mono-
and polyubiquitinated SOD1 (24, 32, 40, 48 kDa spots in two-
dimensional gel electrophoresis) in the Triton X-100-insoluble
FIGURE 4. Purification and analyses of lysylendopeptidase-digested peptides. SOD1s in peaks a and b in
Fig. 3Bwere digested with lysylendopeptidase after treatments with DTT and iodoacetamide, and the digests
were fractionated by HPLC using a TSK-GEL ODS-80TM column. A, chromatogram profiles of the digests from
peaks a (top) and b (bottom), separated with aMonoQ column (Fig. 3B). B, rechromatogram profile of fractions
containing peaks d and e, at the bottom of A. C, MALDI-TOF MS spectra of peptides in factions 1–4 in B.mAU,
milliabsorbance units.
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fraction ofG93A transgenicmice spinal cords. Thus, the 25 kDa
band was speculated to be monoubiquitinated SOD1, and then
the immunostaining with anti-ubiquitin on the same mem-
branewas performed.Although the 25 kDaband appeared to be
one of the ubiquitinated proteins (data not shown), evidence of
monoubiquitination has not been obtained. We are currently
exploring the identity of the molecule bound to Cys111-peroxi-
dized SOD1. Finally, an immunohistochemical study of paraf-
fin-embedded spinal cord sections ofG1H-G93Amicewas per-
formed. The G1H-G93A mice examined at 110 days of age
revealed severe loss of anterior horn cells with gliosis and both
Lewy body-like hyaline inclusions (LBHIs) and vacuolation
pathologies (32). The anti-C111ox-SOD1 selectively labeled
the LBHIs in the neuropil and in the cytoplasm of the neurons
(Fig. 8B) and the rim of the vacuoles in the neuropil (Fig. 8C).
When the paraffin sections were incubated with BSA-PBS
alone or with anti-C111ox-SOD1 pretreated with an excess
amount of air-oxidized SOD1 or peptide containing sulfony-
lated Cys111, no staining was detected. The spinal cords of the
two littermates exhibit neither distinct histopathological
changes nor staining with anti-C111ox-SOD1. These results
suggested that the Cys111-peroxidized SOD1 was involved in
the formation of the LBHIs and the vacuoles in ALS spinal
cords.
DISCUSSION
Because SOD1 catalyzes the conversion of superoxide radi-
cals into molecular oxygen and hydrogen peroxide, SOD1 is
thought to be a major target of oxidative stress. The results of
this study show that the Cys111 residue plays an important role
in oxidative fragmentation and aggregation of human SOD1
(Fig. 2). Moreover, the upper shifted band on reducing SDS-
PAGE generated after oxidation (Fig. 1) was determined to be
an oxidized SOD1 subunit containing sulfinic acid (Cys111-
FIGURE 5. Sequence analysis of modified peptide 92–122 by ESI MS. A, schematic representation of peptides obtained from fragmentations by MS/MS
analysis. B–D, Cys modification observed in this experiment. Carbamidemethyl-Cys (B), sulfinyl Cys (C-SO2H) (C), and sulfonyl Cys (C-SO3H) (D). E–G, MS/MS
sequence analysis of the peptide 92–122 digested with lysylendopeptidase in fractions 1, 3, and 4 (B). E, MS/MS analysis of the peptide modified with
carbamidemethyl-Cys ([M 2H]2 1661.2m/z) in fraction 1. F, MS/MS analysis of the peptide modified with C-SO2H ([M 2H]
2 1648.3 m/z) in fraction
3. G, MS/MS analysis of the peptidemodified with C-SO3H ([M 2H]
2 1657.2 m/z) in fraction 4. The y-ions and b-ions labeled with asterisks are the doubly
charged ions. The mass number labeled with diamond is that of the precursor ion in E–G.
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SO2H) and sulfonic acid (Cys111-SO3H) (Figs. 3–5). The newly
developed specific antibody against a peptide containing
Cys111-SO3H, anti-C111ox-SOD1, recognized the upper band
(Cys111-SO3H form) but not the original band (Cys111-SH
form) by Western blot analyses (Figs. 6–8). These results fur-
ther demonstrated that the upper band is the oxidized form of
SOD1 containing Cys111-SO3H. Although the increment in the
mass, 32 or 48, is small, oxidized SOD1 has slower mobility on
the SDS-PAGE. This phenomenon is, however, frequently
observed in SOD1. For example,mutantG85Rhas fastermobil-
ity in SDS-PAGE, although the difference in themass is 99 (33).
Mouse SOD1 also has faster mobility than human SOD1 in
SDS-PAGE, although both SOD1s have similar molecular
weight (Fig. 8A).
Some cysteine residues are sensitive to oxidation, because
their environment promotes ionization of the thiol (Cys-SH)
group, even at a neural pH, to the thiolate anion (Cys-S),
which is more readily oxidized to sulfenic acid (Cys-SOH) than
is Cys-SH (34, 35). The sulfenic acid group generally is unstable
and reacts with any accessible thiol to form a disulfide (S-S)
bond, or sulfenic acidmay undergo further oxidation to sulfinic
acid (Cys-SO2H) and to sulfonic acid (Cys-SO3H) in the pres-
ence of strong oxidants (34). In the active site of some proteins,
such as Prx and thioredoxin, one cysteine is in the thiolate form
and, as a result, can react withH2O2 (36, 37). In the case of PrxI,
Cys51 is selectively oxidized to Cys-SO2H but not to Cys-SO3H,
as evidenced by the difference of 32 mass units between
reduced and oxidized PrxI proteins. Additional oxidation with
H2O2 did not increase Cys-SO3H even in vitro (22, 34). Cys51-
SO2H is rereduced to Cys51-SH by sulfiredoxin but not by DTT
or thioredoxin (23, 38). In contrast, in intact human SOD1,
Cys111 appears to be oxidized to Cys111-SO3H, even by mild
oxidation in air. As shown in this study, air oxidation of SOD1
resulted in two proteins with a mass unit difference of about 48
(i.e. three oxygen atoms) (Fig. 3). Oxidation of Cys111 occurred
above pH 7, suggesting that Cys111 is in the thiolate form at
physiological pH and can therefore react not only with H2O2
but alsowith oxygen in ambient air (Fig. 1). Cys111 also is readily
modified with N-ethylmaleimide or 4-vinylpyridine (29, 39) or
bound to another sulfhydryl, such as 2-ME (supplemental Fig.
S1) or cysteine (39). In contrast, the free cysteine at residue 6,
Cys6, is less reactive with oxygen, 2-ME, or N-ethylmaleimide
(present study) (29), probably because it exists in-sheet 1a and
is buriedwithin the SOD1molecule (40). In other studies, expo-
sure of bovine SOD1 to an excess of H2O2 resulted in selective
oxidation of His118 (corresponding to His120 in human SOD1),
inactivating the enzyme (2). Rakhit et al. (6) showed that four
amino acids (His48, His80, His120, and Phe20) in human SOD1
were prone to oxidation by ascorbic acid/CuCl2. However, nei-
ther oxidation of His120 in wild-type SOD1 (Fig. 5) nor change
in mass of 2-ME-SOD1 (Fig. 3) by air oxidation was observed.
These results indicate that most amino acids in human SOD1
FIGURE 6. Validation of anti-C111ox-SOD1 that selectively recognizes
Cys111-peroxidized SOD1. A, Western blot analyses for 2-ME-SOD1 and air-
oxidized SOD1 detected by anti-SOD1 (top) and anti-C111ox-SOD1 (bottom).
An arrowhead with solid lines indicates wild-type SOD1 subunits, and arrow-
headswith broken lines indicate Cys111-peroxidized SOD1 subunits. The PVDF
membrane was first reacted with anti-C111ox-SOD1. The antibody was
stripped from the membrane, which was reincubated with anti-SOD1.
B, ELISA for 2-ME-SOD1 and air-oxidized SOD1 treated with and without IA
detected by anti-C111ox-SOD1 (left) and anti-SOD1 (right).Ox,WT, and 2-ME,
air-oxidized SOD1, wild-type SOD1, and 2-ME-SOD1, respectively. Data are
presented as the means S.D. of triplicate experiments.
FIGURE 7. Two-dimensional Western blot analyses for wild-type and
2-MESOD1swithandwithoutoxidationdetectedbyanti-SOD1(A–Dand
F) andanti-C111ox-SOD1 (EandG).5gof SOD1s treatedwithandwithout
1mMH2O2 for 1 h orwith air oxidation for 24 hwere subjected to two-dimen-
sional gel electrophoresis and Western blot analysis. The PVDF membrane
was first reactedwith anti-C111ox-SOD1. The antibodywas stripped from the
membrane, which was reincubated with anti-SOD1.
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are not oxidized by air, the exception being Cys111. Therefore,
these findings demonstrate that, in human SOD1, Cys111 is the
most reactive and sensitive amino acid to oxygen and other
oxidizing agents.
The oxidation of Cys51-SH to Cys51-SO2H causes acidic
shifting of PrxI upon two-dimensional gel electrophoresis (22).
In contrast, human, bovine, and recombinant human SOD1
originally have some charge isomers before oxidation (30, 31).
Fig. 7, A and B, also showed that both wild-type SOD1 and
2-ME-SOD1 have four similar spots, although they have their
own mass. Cys111 oxidation by air oxidation generated two
major spots, 1 and 2, just above the two minor isomers, 1 and
2 (pI 4.92 and 5.02) (Fig. 7, F and G). However, these spots
appear like acidic shifted spots of original main spot 3 (pI 5.15),
because no spot above the main spot was generated by air oxi-
dation. These results suggest that peroxidation of Cys111 also
causes acidic shifting of SOD1. Further oxidation by H2O2 fur-
ther generated several spots, and a total of 13 spots were
observed on two-dimensional gel electrophoresis (Fig. 7D).
Therefore, isomers of SOD1 observed in the previous reports
(13, 26) may be due to both oxidative modification and charge
isomers of SOD1 itself.
Although more than 110 FALS mutations in the SOD1 have
been identified, the mechanism by which the FALS-linked
mutant SOD1s cause motor neuron degeneration is not com-
pletely understood. Two hypotheses have been proposed
explaining the toxic gain of function that is associated with
these mutations (12, 41). The “copper hypothesis” proposes
that copper, either bound to or released from FALS-linked
mutant SOD1s generates reactive oxygen species harmful to
motor neurons (42–44). The “aggregation hypothesis” sup-
poses that FALS-linked mutant SOD1s are structurally unsta-
ble and tend to aggregate, resulting in degeneration of neuronal
cells analogous to that observed in other neurodegenerative
disorders such as Alzheimer, Parkinson, and Huntington dis-
eases (33, 45, 46). However, recent reports suggest that these
two hypotheses are interrelated. Copper ion oxidized Cys111 in
human SOD1 (Fig. 1). Oxidation may result in misfolding and
aggregation even in wild-type SOD1 (6, 47). Oxidized wild-type
SOD1 exhibits characteristics of FALS-linked mutant SOD1s:
conjugation with polyubiquitin, interaction with Hsp70 or
chromogranin B, and toxic effects on motor neurons (7).
Although this study demonstrated that the SH of Cys111 under-
went irreversible peroxidation to Cys-SO2H and to Cys-SO3H,
Cys111 may also participate in disulfide bond linkage with other
cysteine residues and oligomerization (48). Furukawa et al.
(49–51) showed that incorrect intermolecule disulfide cross-
linking of immature, misfolded FALS-linked mutant SOD1s
leads to formation of insoluble aggregates. On the other hand,
an immunohistochemical study using the anti-C111ox-SOD1
revealed that Cys111-peroxidizedmutant SOD1 accumulated in
the vacuole structures and LBHIs (Fig. 8, B and C). Because the
most characteristic neuropathological findings in ALS model
mice are LBHIs and vacuoles (32, 33), the peroxidation of
Cys111 may contribute to the pathology of the degeneration/
death of FALS motor neurons. However, the amount of the
Cys111-peroxidized SOD1 appears to be quite limited (Fig. 8A).
Large quantities of thiol compounds, such as glutathione and
cysteine, probably protect the SH of Cys111 in healthy cells. The
surviving neuron cells were not immunostained by anti-
C111ox-SOD (Fig. 8, B and C). Ferri et al. (48) proposed that
Cys111 was a key mediator of mitochondrial association of
SOD1 and subsequent mitochondrial dysfunction, because the
C111Smutant was less associatedwithmitochondria. Recently,
it was also reported that A4V/C111S protein was more stable
than A4V protein in cells (52). However, it is still an open ques-
tion whether Cys111 is essential for the etiology of ALS, because
mice that express mouse SOD1-G85R developed ALS-like
symptoms, although Ser, not Cys, is at residue 111 of mouse
SOD1 (53). It is thought that Cys111 may enhance human ALS
development. A comparative study of symptoms between mice
expressing the ALS mutation with C111S (G93A/C111S etc.)
and traditional ALS model mice (G93A etc.) would answer the
question.
In summary, we demonstrated that Cys111 in human SOD1 is
a primary target for oxidation and is readily oxidized to Cys111-
SO3H. The specific antibody against the Cys111-SO3H will be a
useful tool for detecting oxidized human SOD1. Precise studies
of the role of oxidized SOD1 in ALS are currently under way.
FIGURE 8. Cys111-peroxidized SOD1 in spinal cord of G1H-G93A mice.
A, Western blot analyses for G1H-G93A spinal cord extracts detected by
anti-C111ox-SOD1 (left) and anti-SOD1 (right). 60 g of proteins of buffer-
soluble (B), Triton X-100-soluble (T), and SDS-soluble (S) fractions, respec-
tively, were applied. The arrowheads with solid lines indicate human and
mouse SOD1 subunits, and a double arrowheadwith a broken line indicates
Cys111-peroxidized SOD1 subunits. The arrowheads indicate a 25 kDa
band reacted with anti-C111ox-SOD1. 20 ng of air-oxidized SOD1 (Ox) and
wild-type SOD1 (WT) were applied as controls. The PVDF membrane was
first reacted with anti-C111ox-SOD1. The antibody was stripped from the
membrane, which was reincubated with anti-SOD1. Precision Plus protein
standards purchased from Bio-Rad were used as molecular weight mark-
ers. B and C, immunohistochemical analyses of paraffin-embedded G1H-
G93A spinal cord sections detected by anti-C111ox-SOD1. B, double
arrows indicate LBHIs in the neuropil and in the cytoplasm of the neurons
immunostained with anti-C111ox-SOD1. A single arrow indicates a rim of
the vacuoles in the neuropil immunostained with anti-C111ox-SOD1. An
arrowhead indicates the survivingmotor neuron, which is not stainedwith
anti-C111ox-SOD1. Scale bar, 25m. C, single arrows indicate rims of vacu-
oles detected by anti-C111ox-SOD1. An arrowhead indicates the surviving
motor neuron, which is not stained with anti-C111ox-SOD1. Scale bar,
50 m.
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